Search Results - "Orens, J. B."

Refine Results
  1. 1

    High‐Quality CMV‐Specific CD4+ Memory Is Enriched in the Lung Allograft and Is Associated With Mucosal Viral Control by Akulian, J. A., Pipeling, M. R., John, E. R., Orens, J. B., Lechtzin, N., McDyer, J. F.

    Published in American journal of transplantation (01-01-2013)
    “…The maintenance of CMV‐specific T cell memory in lung transplant recipients (LTRs) is critical for host defense and allograft durability, particularly in…”
    Get full text
    Journal Article
  2. 2

    Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness by Studer, S.M, Levy, R.D, McNeil, K, Orens, J.B

    Published in The European respiratory journal (01-10-2004)
    “…The success of lung transplantation has improved over time as evidenced by better long-term survival and functional outcomes. Despite the success of this…”
    Get full text
    Journal Article
  3. 3

    Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection by Studer, S M, Orens, J B, Rosas, I, Krishnan, J A, Cope, K A, Yang, S, Conte, J V, Becker, P B, Risby, T H

    “…Obliterative bronchiolitis (OB) remains one of the leading causes of death in lung transplant recipients after 2 years, and acute rejection (AR) of lung…”
    Get more information
    Journal Article
  4. 4

    Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension by YUAN, J. X.-J, ALDINGER, A. M, JUHASZOVA, M, JIAN WANG, CONTE, J. V, GAINE, S. P, ORENS, J. B, RUBIN, L. J

    Published in Circulation (New York, N.Y.) (06-10-1998)
    “…Primary pulmonary hypertension (PPH) is a rare disease of unknown cause. Although PPH and secondary pulmonary hypertension (SPH) share many clinical and…”
    Get full text
    Journal Article
  5. 5

    CD154 Deficiency Uncouples Allograft CD8+ T‐Cell Effector Function from Proliferation and Inhibits Murine Airway Obliteration by Shah, P. D., West, E. E., Whitlock, A. B., Orens, J. B., McDyer, J. F.

    Published in American journal of transplantation (01-12-2009)
    “…Obliterative bronchiolitis (OB) limits the long‐term success of lung transplantation, while T‐cell effector mechanisms in this process remain incompletely…”
    Get full text
    Journal Article
  6. 6

    The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study by Orens, J B, Kazerooni, E A, Martinez, F J, Curtis, J L, Gross, B H, Flint, A, Lynch, 3rd, J P

    Published in Chest (01-07-1995)
    “…To assess the sensitivity of high-resolution chest computed tomography (HRCT) in detecting idiopathic pulmonary fibrosis proved by biopsy specimen. To…”
    Get more information
    Journal Article
  7. 7

    Thoracic Organ Transplantation in the United States, 1995–2004 by Orens, J. B., Shearon, T. H., Freudenburger, R. S., Conte, J. V., Bhorade, S. M., Ardehali, A.

    Published in American journal of transplantation (01-05-2006)
    “…This article reviews trends in thoracic organ transplantation based on OPTN/SRTR data from 1995 to 2004. The number of active waiting list patients for heart…”
    Get full text
    Journal Article
  8. 8

    The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation by Conte, J V, Gaine, S P, Orens, J B, Harris, T, Rubin, L J

    “…Primary pulmonary hypertension (PPH) is a progressive disease with a median survival of less than 3 years from diagnosis. Medical management has typically…”
    Get more information
    Journal Article
  9. 9

    The Effect of the Cystic Fibrosis Care Center on Lung Transplant Outcomes by Krishnan, A., Bush, E.L., Chidi, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Orens, J.B., Ha, J., Shah, P., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A.

    “…Since 1961 the Cystic Fibrosis Foundation has designated certain institutions devoted to treating cystic fibrosis (CF) as Cystic Fibrosis Care Centers (CFCC)…”
    Get full text
    Journal Article
  10. 10

    Simulated Regionalization of Heart and Lung Transplantation in the United States by Magruder, J. T., Shah, A. S., Crawford, T. C., Grimm, J. C., Kim, B., Orens, J. B., Bush, E. L., Higgins, R. S., Merlo, C. A.

    Published in American journal of transplantation (01-02-2017)
    “…We simulated the impact of regionalization of isolated heart and lung transplantation within United Network for Organ Sharing (UNOS) regions. Overall, 12 594…”
    Get full text
    Journal Article
  11. 11

    Splenic Irradiation for the Treatment of Severe Antibody‐Mediated Rejection by Orandi, B. J., Lonze, B. E., Jackson, A., Terezakis, S., Kraus, E. S., Alachkar, N., Bagnasco, S. M., Segev, D. L., Orens, J. B., Montgomery, R. A.

    Published in American journal of transplantation (01-10-2016)
    “…Patients requiring desensitization prior to renal transplantation are at risk for developing severe antibody‐mediated rejection (AMR) refractory to treatment…”
    Get full text
    Journal Article
  12. 12

    Allograft Injury and Outcomes in African American Lung Transplant Recipients by Agbor-Enoh, S., Charya, A., Jang, M., Luikart, H., Shah, P., Matthews, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Bhatti, K., Marishta, A., Yang, Y., Tunc, I., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K., Orens, J.B., Valantine, H.

    “…African American patients (AA) have poorer outcomes than White patients (W) after heart and kidney transplant. Little is known about differential outcomes in…”
    Get full text
    Journal Article
  13. 13

    Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines by Silverman, H J, Penaranda, R, Orens, J B, Lee, N H

    Published in Critical care medicine (01-01-1993)
    “…To determine whether myocardial hyporesponsiveness to administered catecholamines occurs in human sepsis and whether this phenomenon is associated with…”
    Get more information
    Journal Article
  14. 14

    Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers by Chidi, A.P., Krishnan, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Thaxton, A., Orens, J.B., Ha, J., Shah, P.D., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A., Bush, E.L.

    “…Clinical outcomes remain extremely poor for children with cystic fibrosis undergoing lung transplantation. Since 1961, the Cystic Fibrosis Foundation has…”
    Get full text
    Journal Article
  15. 15

    Improved Survival after Repeat Lung Transplantation at Cystic Fibrosis Care Centers by Chidi, A.P., Krishnan, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Thaxton, A., Orens, J.B., Ha, J.S., Shah, P.D., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A., Bush, E.L.

    “…Patients who undergo repeat lung transplantation (LT) are at high risk for perioperative complications. The complexity of their care requires specialized…”
    Get full text
    Journal Article
  16. 16

    Pleuropulmonary manifestations of systemic lupus erythematosus by Orens, J B, Martinez, F J, Lynch, 3rd, J P

    “…The pleuropulmonary manifestation of systemic lupus erythematous (SLE) are pleuritis, acute lupus pneumonitis, chronic interstitial lung disease with fibrosis,…”
    Get more information
    Journal Article
  17. 17

    Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy by Shannon, J J, Bude, R O, Orens, J B, Becker, F S, Whyte, R I, Rubin, J M, Quint, L E, Martinez, F J

    “…We conducted a randomized, controlled trial to prospectively confirm that ultrasound-directed transbronchial needle aspiration (USTBNA) results in: (1)…”
    Get more information
    Journal Article
  18. 18

    Lung transplantation for pulmonary hypertension by Orens, J B

    “…Lung transplantation is an accepted therapeutic intervention for patients with pulmonary arterial hypertension (PAH) who fail medical therapy. Highly selected…”
    Get full text
    Journal Article
  19. 19

    High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations by Kennedy, A S, Sonett, J R, Orens, J B, King, K

    “…Significant anastomotic stenosis and malacia is reported to affect 7% to 15% of lung transplant recipients. Laser debridement, dilation and stenting can be…”
    Get more information
    Journal Article
  20. 20

    Recurrence of sarcoidosis following bilateral allogeneic lung transplantation by Martinez, F J, Orens, J B, Deeb, M, Brunsting, L A, Flint, A, Lynch, 3rd, J P

    Published in Chest (01-11-1994)
    “…We report the first case of recurrent sarcoidosis manifested by clinical symptoms, radiographic abnormalities, and pathologic changes in a patient following…”
    Get more information
    Journal Article